Modification of the equine gastrointestinal microbiota by Jerusalem artichoke meal supplementation.

The objective of this study was to investigate the impact of natural prebiotic active compounds on the microbial composition in different regions of the equine gastrointestinal tract. Twelve adult horses (body weight [bwt] 534 ± 64.5 kg; age 14 ± 7.5 years) were randomly divided into two feeding groups. Six horses received a basal diet consisting of 1.5 kg hay/100 kg bwt x d-1 and oat grains equal to 1.19 g starch/kg bwt x d-1, supplemented with Jerusalem artichoke meal providing prebiotic fructooligosaccharides + inulin in a quantity of 0.15 g/kg bwt x d-1. The remaining horses received a placebo added to the basal diet. The horses were fed for 21 d and euthanized at the end of the feeding period. Digesta samples from different parts of the gastrointestinal tract were taken, DNA extracted and the V1-V2 region of the 16S rRNA gene amplified. Supplementation with the prebiotic increased the relative abundance of Lactobacillus (P < 0.05), with a concurrent reduction of the relative abundance of Streptococcus mainly in the stomach (P < 0.05). In the hindgut, the supplemental prebiotic also increased the relative abundance of Lactobacillus but further reduced the relative abundance of fibrolytic bacteria, specifically the unclassified members of the families Lachnospiraceae (P < 0.05) and Ruminococcaceae. The relative abundance of the genus Ruminococcus increased solely in the caecum and colon transversum. Overall, the addition of the prebiotic significantly increased the diversity in nearly all parts of the gastrointestinal tract (P < 0.05). The feeding of this natural prebiotic compound to horses had an impact on the microbial community in the entire gastrointestinal tract. Furthermore, the effect on the bacterial community in the foregut (especially the stomach) was more pronounced in comparison to the effect in the hindgut. Therefore, the impact on stomach health should be carefully considered.

Changes in rumen microbiota composition and in situ degradation kinetics during the dry period and early lactation as affected by rate of increase of concentrate allowance.

Changes in rumen microbiota and in situ degradation kinetics were studied in 12 rumen-cannulated Holstein Friesian dairy cows during the dry period and early lactation. The effect of a rapid (RAP) or gradual (GRAD) postpartum (pp) rate of increase of concentrate allowance was also investigated. Cows were fed for ad libitum intake and had free access to a mixed ration consisting of chopped wheat straw (dry period only), grass silage, corn silage, and soybean meal. Treatment consisted of either a rapid (1.0 kg of dry matter/d; n = 6) or gradual (0.25 kg of dry matter/d; n = 6) increase of concentrate allowance (up to 10.9 kg of dry matter/d), starting at 4 d pp. In whole rumen contents, bacterial community composition was assessed using samples from 50, 30, and 10 d antepartum (ap), and 3, 9, 16, 30, 44, 60, and 80 d pp, and protozoal and archaeal community composition using samples from 10 d ap, and 16 and 44 d pp. Intake of fermentable organic matter, starch, and sugar was temporarily greater in RAP than GRAD at 16 d pp. Bacterial community richness was higher during the dry period than during the lactation. A rapid increase in concentrate allowance decreased bacterial community richness at 9 and 16 d pp compared with a gradual increase in concentrate allowance, whereas from 30 d pp onward richness of RAP and GRAD was similar. In general, the relative abundances of Bacteroidales and Aeromonadales were greater, and those of Clostridiales, Fibrobacterales, and Spirochaetales were smaller, during the lactation compared with the dry period. An interaction between treatment and sampling day was observed for some bacterial community members, and most of the protozoal and archaeal community members. Transition to lactation increased the relative abundance of Epidinium and Entodinium, but reduced the relative abundance of Ostracodinium. Archaea from genus Methanobrevibacter dominated during both the dry period and lactation. However, during lactation the abundance of the methylotrophic Methanomassiliicoccaceae and Methanosphaera increased. The in situ degradation of organic matter, neutral detergent fiber, starch, and crude protein was neither affected by treatment nor by transition from the dry period to lactation. Results show that the composition of the rumen microbiota can change quickly from the dry period to the lactation period, in particular with a rapid increase in fermentable substrate supply postpartum, but this was not associated with changes in rumen degradation kinetics.

Expression of p53 as predictor for the development of esophageal cancer in achalasia patients.

Patients with longstanding achalasia have an increased risk of developing esophageal cancer. Surveillance is hampered by chronic stasis. We investigated whether aberrant expressions of tumor suppressor gene p53 and proliferation marker ki67 are early predictors for progression to malignancy. In 399 achalasia patients, 4% died of esophageal cancer despite surveillance. We performed a cohort study, using surveillance biopsies from 18 patients (11 carcinoma, one high-grade dysplasia [HGD], and six low-grade dysplasia [LGD]) and 10 controls (achalasia patients without cancer or dysplasia development). One hundred sixty-four biopsies were re-evaluated and studied for p53 and ki67 expression using immunohistochemistry. Eighty-two percent of patients with cancer/HGD showed p53 overexpression in surveillance biopsies at a mean of 6 (1-11) years prior to cancer development. In 67% of patients with LGD and only in 10% of the controls p53 overexpression was present. The proportion of samples with p53 overexpression increased with increasing grades of dysplasia. We found no difference for ki67 overexpression. p53 overexpression may identify achalasia patients at increased risk of developing esophageal carcinoma. Further study is needed to determine if patients with p53 overexpression would benefit from intensive surveillance to detect esophageal neoplasia at a potential curable stage.